The Patent Finder

Aradigm Corporation

Also on record
Records under this name other than patents Aradigm Corporation holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Back to Aradigm Corporation

PatentTitleStatus Expires Confidence
US 8,268,347Dual action, inhaled formulations providing both an immediate and sustained release profile
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 9,844,548Liposomal ciprofloxacin formulations with encapsulated ciprofloxacin nanocrystals
Formerly held
Lapsed on the fee record
Ended Dec 19, 2025 · From the USPTO record
Lapsed on the fee recordEnded Dec 19, 2025From the USPTO record
US 11,026,941Concentrated, inhalable ciprofloxacin formulation
Formerly held
Lapsed on the fee record
Ended Jun 8, 2025 · From the USPTO record
Lapsed on the fee recordEnded Jun 8, 2025From the USPTO record
US 8,414,915Dual action, inhaled formulations providing both an immediate and sustained release profile
Formerly held
Lapsed on the fee record
Ended Apr 9, 2025 · From the USPTO record
Lapsed on the fee recordEnded Apr 9, 2025From the USPTO record
US 9,545,401Concentrated, inhalable ciprofloxacin formulation
Formerly held
Lapsed on the fee record
Ended Jan 17, 2025 · From the USPTO record
Lapsed on the fee recordEnded Jan 17, 2025From the USPTO record
US 9,532,986Liposomal ciprofloxacin formulations with activity against non-tuberculous mycobacteria
Formerly held
Lapsed on the fee record
Ended Jan 3, 2025 · From the USPTO record
Lapsed on the fee recordEnded Jan 3, 2025From the USPTO record
US 8,119,156Dual action, inhaled formulations providing both an immediate and sustained release profile
Formerly held
Lapsed on the fee record
Ended Feb 21, 2024 · From the USPTO record
Lapsed on the fee recordEnded Feb 21, 2024From the USPTO record
US 9,259,424Concentrated, inhalable antibiotic formulation
Formerly held
Lapsed on the fee record
Ended Feb 16, 2024 · From the USPTO record
Lapsed on the fee recordEnded Feb 16, 2024From the USPTO record
US 8,256,433Systems and methods for effecting cessation of tobacco use
Term ended
Term ended Jan 7, 2024 · From the USPTO record
Term endedTerm ended Jan 7, 2024From the USPTO record
US 8,071,127Dual action, inhaled formulations providing both an immediate and sustained release profile
Formerly held
Lapsed on the fee record
Ended Dec 6, 2023 · From the USPTO record
Lapsed on the fee recordEnded Dec 6, 2023From the USPTO record
10 of 166 patents shown.
Pro members see all 166.
Pro members: see all 166 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited